生物活性 | |||
---|---|---|---|
描述 | Oxyclozanide (OXZ) is a salicylanilide anthelmintic drug that mainly acts by uncoupling oxidative phosphorylation in flukes. Goats treated with LVM (levamisole)-OXZ combination at the recommended dose for sheep may result in a reduced efficacy, because of under-dosing, which may increase the risk of drug resistance in parasites[1]. Oxyclozanide in combination with colistin increased the activity of colistin against Col-S and Col-R A. baumannii, P. aeruginosa and K. pneumoniae. Time-kill curves showed synergistic activity between oxyclozanide and colistin against these bacterial isolates. Moreover, Col-R (colistin-resistant) A. baumannii, P. aeruginosa and K. pneumoniae in the presence of oxyclozanide presented greater permeability and disruption of their cell wall than Col-S (colistin against colistin-susceptible) strains, without modification of their outer membrane protein profile[2]. The LD50 of oxyclozanide was ~3,707 mg/kg body weight, and the lowest observed adverse effect level of oxyclozanide was at a dose of 74 mg/kg in rats[3]. Oxyclozanide demonstrated in-vitro antibacterial activity against meticillin-resistant S. pseudintermedius[4]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.49mL 0.50mL 0.25mL |
12.45mL 2.49mL 1.25mL |
24.91mL 4.98mL 2.49mL |
参考文献 |
---|